About Conference
OMICS International Conferences invites all the participants from all over the world to attend '4th International Conference on Vascular Dementia' with the Theme: "Integrating Recent Discoveries and Interpreting Vascular Dementia Research for Better Health" during June 30 - July 02, 2016 at Valencia, Spain which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
The term Dementia describes a loss of mental ability (cognitive impairment) associated with gradual death of brain cells. Vascular Dementia can be caused by a number of different diseases, usually neurodegenerative diseases, such as Alzheimer's disease, front temporal dementia and dementia with Lewy bodies. Vascular dementia is caused when the brain's blood supply is restricted or stopped, leading brain cells to die.
Vascular dementia is the second-most-common type of dementia in the United States and Europe in the elderly, however it is the most common form in some parts of Asia. The incidence of the illness is 1.5% in Western countries and just about 2.2% in Japan. It accounts for 50% of all dementias in Japan, 20% to 40% in Europe and 15% in Latin America. The prevalence of dementia is 9 times higher in patients who have had a stroke than in controls. 25% of stroke patients develop new-onset dementia within 1 year of their stroke. The relative risk of incident dementia is 5.5% within 4 years of suffering a stroke.
The overall multi infarct dementia market is segmented into North America, Asia Pacific, Europe, Latin America and MEA. As of 2014, North America held largest market share in terms of revenue owing to the increasing incidences of multi infarct dementia coupled with increasing geriatric population base. European market displayed similar traits and followed North American multi infarct dementia market. Asia Pacific is expected to grow at a high pace due to increasing awareness about prevention of brain strokes in this region. Japan owing to increased geriatric base represents approximately more than 50% of the dementia cases in Asia Pacific. The developed nations such as Japan, Canada, France, Germany and U.S. are anticipated to witness favourable growth over the forecast period.
Various companies in the multi infarct dementia market are adopting several economical strategies such as collaborations, expansions and acquisitions to keep a strong position and gain advantage in the market. Some major companies in the market include Forest Laboratories, Inc., Janssen Pharmaceuticals, Inc., Novartis Pharmaceutical Corporation, Pfizer, Inc. and Eisai, Inc.
Why to attend ?
Vascular Dementia Conference is a unique forum to bring together worldwide distinguished academics in the field of Neuroscience and Neurology, Nutrition, Researchers, Public health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the Research and Development.
Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum ofVascular Dimentia. A Unique Opportunity for Advertisers and Sponsors at this International event.
Target Audience
Business delegates, Industrial Leaders, Vascular Dementia Researchers, Neurologist, Neuroscientist, Neurosurgeons, CEO's and R&D Heads from Industries, Directors, Psychiatrist, Nutritional Scientists, Head of department, Vascular Dementia Coach, Professors and Students from Academia in the research of vascular dementia.
Conference Highlights
- Dementia
- Semantic Dementia
- Front temporal Dementia
- Mild Dementia
- Severe Dementia
- Dementia Care
- Lewy Body Dementia
- Vascular Dementia
- Advances in Dementia Test
- Dementia Stages
- Lewy Body Dementia Stages
- Frontal Dementia
- Alcoholic Dementia
- Diagnosis of Dementia
- Dementia Pathophysiology
- Vascular Dementia Nursing
- Ageing and Dementia
- Potential Future Interventions
- Sudden Dementia
- Neuropharmacology
- Neuropediatrics
- Advanced Drug for Dementia
- Neuroimmunology
- Neuro-entrepreneurship: Vascular Dementia
Special Issues
- All accepted abstracts will be published in respective OMICS International Journals.
- Abstracts will be provided with Digital Object Identifier by Cross Ref.
See more at: http://vasculardementia.conferenceseries.com/
